检索结果-内蒙古大学图书馆

Author Correction: Validating a breast cancer score in Spanish women. The MCC-Spain study

Scientific reports 2020年第1期10卷 5980页

作者： Trinidad Dierssen-Sotos Inés Gómez-Acebo Camilo Palazuelos Pablo Fernández-Navarro Jone M Altzibar Carmen González-Donquiles Eva Ardanaz Mariona Bustamante Jessica Alonso-Molero Carmen Vidal Juan Bayo-Calero Adonina Tardón Dolores Salas Rafael Marcos-Gragera Víctor Moreno Paz Rodriguez-Cundin Gemma Castaño-Vinyals María Ederra Laura Vilorio-Marqués Pilar Amiano Beatriz Pérez-Gómez Nuria Aragonés Manolis Kogevinas Marina Pollán Javier Llorca CIBER Epidemiología y Salud Pública (CIBERESP) Madrid Spain. dierssent@unican.es. University of Cantabria - IDIVAL Santander Spain. dierssent@unican.es. CIBER Epidemiología y Salud Pública (CIBERESP) Madrid Spain. University of Cantabria - IDIVAL Santander Spain. Cancer and Environmental Epidemiology Unit National Center for Epidemiology Carlos III Institute of Health Madrid Spain. Cancer Epidemiology Research Group Oncology and Hematology Area IIS Puerta de Hierro (IDIPHIM) Madrid Spain. Breast Cancer Screening Programme Basque Health Department Osakidetza Spain. Grupo de Investigación Interacciones Gen-Ambiente y Salud Universidad de León León Spain. Navarra Public Health Institute Navarra Spain. IdiSNA Navarra Institute for Health Research Pamplona Spain. ISGlobal Centre for Research in Environmental Epidemiology (CREAL) Barcelona Spain. Centre for Genomic Regulation (CRG) the Barcelona Institute of Science and Technology Barcelona Spain. Universitat Pompeu Fabra (UPF) Barcelona Spain. Cancer Prevention and Control Program Catalan Institute of Oncology-IDIBELL L'Hospitalet de Llobregat Barcelona Spain. Complejo Hospitalario Universitario de Huelva Centro de Investigación en Salud y Medio Ambiente (CYSMA) Universidad de Huelva Huelva Spain. IUOPA Universidad de Oviedo Asturias Spain. Valencia Cancer and Public Health Area FISABIO - Public Health Valencia Spain. General Directorate Public Health Valencian Community Valencia Spain. Catalan Institute of Oncology Girona Spain. Department of Clinical Sciences Faculty of Medicine University of Barcelona Barcelona Spain. University Hospital Marques de Valdecilla - IDIVAL Santander Spain. IMIM (Hospital Del Mar Medical Research Institute) Barcelona Spain. Public Health Division of Gipuzkoa BioDonostia Research Institute San Sebastian Spain. School of Public Health Athens Greece.

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

关键词：

来源：评论

学校读者我要写书评

暂无评论

Correction to: Association of dietary inflammatory potential with cardiometabolic risk factors and diseases: a systematic review and dose-response meta-analysis of observational studies

引用

Diabetology & metabolic syndrome 2020年第1期12卷 106页

作者： Zahra Aslani Omid Sadeghi Motahar Heidari-Beni Hoda Zahedi Fereshteh Baygi Nitin Shivappa James R Hébert Sajjad Moradi Gity Sotoudeh Hamid Asayesh Shirin Djalalinia Mostafa Qorbani Department of Community Nutrition School of Nutritional Sciences and Dietetics Tehran University of Medical Sciences Tehran Iran. Students' Scientific Research Center Tehran University of Medical Sciences Tehran Iran. Child Growth and Development Research Center Research Institute for Primordial Prevention of Non-Communicable Disease Isfahan University of Medical Sciences Isfahan Iran. Hematopoietic Stem Cell Research Center Shahid Beheshti University of Medical Sciences Tehran Iran. Center of Maritime Health and Society Department of Public Health University of Southern Denmark Esbjerg Denmark. Cancer Prevention and Control Program University of South Carolina Columbia SC 29208 USA. Department of Epidemiology and Biostatistics Arnold School of Public Health University of South Carolina Columbia SC 29208 USA. Connecting Health Innovations LLC Columbia SC 29201 USA. Halal Research Center of IRI FDA Tehran Iran. Department of Clinical Nutrition School of Nutrition and Food Science Isfahan University of Medical Sciences Isfahan Iran. Department of Medical Emergencies Qom University of Medical Sciences Qom Iran. Development of Research & Technology Center Ministry of Health and Medical Education Tehran Iran. Non-Communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran Iran. Non-Communicable Diseases Research Center Alborz University of Medical Sciences Karaj Iran. mqorbani1379@***. Chronic Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran Iran. mqorbani1379@***.

An amendment to this paper has been published and can be accessed via the original article.

关键词：

来源：评论

学校读者我要写书评

暂无评论

Software for administering the National cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events: Usability study

引用

JMIR Human Factors 2018年第3期5卷 e10070页

作者： Schoen, Martin W. Basch, Ethan Hudson, Lori L. Chung, Arlene E. Mendoza, Tito R. Mitchell, Sandra A. St. Germain, Diane Baumgartner, Paul Sit, Laura Rogak, Lauren J. Shouery, Marwan Shalley, Eve Reeve, Bryce B. Fawzy, Maria R. Bhavsar, Nrupen A. Cleeland, Charles Schrag, Deborah Dueck, Amylou C. Abernethy, Amy P. Division of Hematology and Medical Oncology Department of Internal Medicine Saint Louis University School of Medicine Saint Louis MO United States Division of Hematology/Oncology Department of Medicine University of North Carolina School of Medicine 170 Manning Drive Chapel Hill NC United States Department of Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Center New York NY United States Lineberger Comprehensive Cancer Center University of North Carolina Chapel Hill NC United States Department of Health Policy and Management Gillings School of Public Health University of North Carolina Chapel Hill NC United States Duke Clinical Research Institute Duke University Durham NC United States Division of General Medicine and Clinical Epidemiology Department of Medicine University of North Carolina School of Medicine Chapel Hill NC United States Division of General Pediatrics and Adolescent Medicine Department of Pediatrics Program on Health and Clinical Informatics University of North Carolina School of Medicine Chapel Hill NC United States Department of Symptom Research University of Texas MD Anderson Cancer Center Houston TX United States Division of Cancer Control and Population Sciences National Cancer Institute Rockville MD United States Division of Cancer Prevention National Cancer Institute Rockville MD United States SemanticBits Herndon VA United States Center for Biomedical Informatics and Information Technology National Cancer Institute Rockville MD United States Duke Cancer Institute Durham NC United States FHI 360 Durham NC United States Division of General Internal Medicine Duke University School of Medicine Durham NC United States Division of Population Sciences Dana-Farber Cancer Institute Boston MA United States Alliance Statistics and Data Center Mayo Clinic Scottsdale AZ United States Flatiron Health New York NY United States

Background: The US National cancer Institute (NCI) developed software to gather symptomatic adverse events directly from patients participating in clinical trials. The software administers surveys to patients using items from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) through Web-based or automated telephone interfaces and facilitates the management of survey administration and the resultant data by professionals (clinicians and research associates). Objective: The purpose of this study was to iteratively evaluate and improve the usability of the PRO-CTCAE software. Methods: Heuristic evaluation of the software functionality was followed by semiscripted, think-aloud protocols in two consecutive rounds of usability testing among patients with cancer, clinicians, and research associates at 3 cancer centers. We conducted testing with patients both in clinics and at home (remotely) for both Web-based and telephone interfaces. Furthermore, we refined the software between rounds and retested. Results: Heuristic evaluation identified deviations from the best practices across 10 standardized categories, which informed initial software improvement. Subsequently, we conducted user-based testing among 169 patients and 47 professionals. Software modifications between rounds addressed identified issues, including difficulty using radio buttons, absence of survey progress indicators, and login problems (for patients) as well as scheduling of patient surveys (for professionals). The initial System Usability Scale (SUS) score for the patient Web-based interface was 86 and 82 (P=.22) before and after modifications, respectively, whereas the task completion score was 4.47, which improved to 4.58 (P=.39) after modifications. Following modifications for professional users, the SUS scores improved from 71 to 75 (P=.47), and the mean task performance improved significantly (4.40 vs 4.02;P=.001). Conclusions: Software modificati

关键词： Adverse events cancer clinical trials Patient-reported outcomes PRO-CTCAE Symptoms Usability

来源：评论

学校读者我要写书评

暂无评论

Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

引用

Nature genetics 2019年第7期51卷 1191-1192页

作者： Valérie Turcot Yingchang Lu Heather M Highland Claudia Schurmann Anne E Justice Rebecca S Fine Jonathan P Bradfield Tõnu Esko Ayush Giri Mariaelisa Graff Xiuqing Guo Audrey E Hendricks Tugce Karaderi Adelheid Lempradl Adam E Locke Anubha Mahajan Eirini Marouli Suthesh Sivapalaratnam Kristin L Young Tamuno Alfred Mary F Feitosa Nicholas G D Masca Alisa K Manning Carolina Medina-Gomez Poorva Mudgal Maggie C Y Ng Alex P Reiner Sailaja Vedantam Sara M Willems Thomas W Winkler Gonçalo Abecasis Katja K Aben Dewan S Alam Sameer E Alharthi Matthew Allison Philippe Amouyel Folkert W Asselbergs Paul L Auer Beverley Balkau Lia E Bang Inês Barroso Lisa Bastarache Marianne Benn Sven Bergmann Lawrence F Bielak Matthias Blüher Michael Boehnke Heiner Boeing Eric Boerwinkle Carsten A Böger Jette Bork-Jensen Michiel L Bots Erwin P Bottinger Donald W Bowden Ivan Brandslund Gerome Breen Murray H Brilliant Linda Broer Marco Brumat Amber A Burt Adam S Butterworth Peter T Campbell Stefania Cappellani David J Carey Eulalia Catamo Mark J Caulfield John C Chambers Daniel I Chasman Yii-Der I Chen Rajiv Chowdhury Cramer Christensen Audrey Y Chu Massimiliano Cocca Francis S Collins James P Cook Janie Corley Jordi Corominas Galbany Amanda J Cox David S Crosslin Gabriel Cuellar-Partida Angela D'Eustacchio John Danesh Gail Davies Paul I W Bakker Mark C H Groot Renée Mutsert Ian J Deary George Dedoussis Ellen W Demerath Martin Heijer Anneke I Hollander Hester M Ruijter Joe G Dennis Josh C Denny Emanuele Di Angelantonio Fotios Drenos Mengmeng Du Marie-Pierre Dubé Alison M Dunning Douglas F Easton Todd L Edwards David Ellinghaus Patrick T Ellinor Paul Elliott Evangelos Evangelou Aliki-Eleni Farmaki I Sadaf Farooqi Jessica D Faul Sascha Fauser Shuang Feng Ele Ferrannini Jean Ferrieres Jose C Florez Ian Ford Myriam Fornage Oscar H Franco Andre Franke Paul W Franks Nele Friedrich Ruth Frikke-Schmidt Tessel E Galesloot Wei Gan Ilaria Gandin Paolo Gasparini Jane Gibson Vilmantas Giedraitis Anette P Gjesing Penny Gordon-Larsen Mathias Gorski Hans-Jörgen Montreal Heart Institute Université de Montréal Montreal Quebec Canada. Division of Epidemiology Department of Medicine Vanderbilt-Ingram Cancer Center Vanderbilt Epidemiology Center Vanderbilt University School of Medicine Nashville TN USA. Charles Bronfman Institute for Personalized Medicine Icahn School of Medicine at Mount Sinai New York NY USA. Genetics of Obesity and Related Metabolic Traits Program Icahn School of Medicine at Mount Sinai New York NY USA. Department of Epidemiology University of North Carolina Chapel Hill NC USA. Human Genetics Center University of Texas School of Public Health University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences University of Texas Health Science Center at Houston Houston TX USA. Broad Institute of MIT and Harvard Cambridge MA USA. Department of Genetics Harvard Medical School Boston MA USA. Division of Endocrinology and Center for Basic and Translational Obesity Research Boston Children's Hospital Boston MA USA. Center for Applied Genomics Division of Human Genetics Children's Hospital of Philadelphia Philadelphia PA USA. Quantinuum Research LLC San Diego CA USA. Estonian Genome Center University of Tartu Tartu Estonia. Division of Epidemiology Department of Medicine Institute for Medicine and Public Health Vanderbilt Genetics Institute Vanderbilt University Nashville TN USA. Institute for Translational Genomics and Population Sciences LABioMed at Harbor-UCLA Medical Center Torrance CA USA. Wellcome Trust Sanger Institute Hinxton UK. Department of Mathematical and Statistical Sciences University of Colorado Denver CO USA. Wellcome Trust Centre for Human Genetics University of Oxford Oxford UK. Department of Biological Sciences Faculty of Arts and Sciences Eastern Mediterranean University Famagusta Cyprus. Max Planck Institute of Immunobiology and Epigenetics Freiburg Germany. Department of Biostatistics and Center for Statistical Genetics University of M

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

关键词：

来源：评论

学校读者我要写书评

暂无评论

A second update on mapping the human genetic architecture of COVID-19

引用

Nature 2023年第7977期621卷 E7-E26页

作者： Masahiro Kanai Christine Stevens Benjamin M. Neale Mark Daly Andrea Ganna Amy Trankiem Mary K. Balaconis Samuli Ripatti Lindo Nkambul Mark J. Daly Sam Bryant Matthew Solomonson Shea J. Andrews Mattia Cordioli Juha Karjalainen Juha Mehtonen Matti Pirinen Andrea Corbetta Bradley Jermy Kati Donner Katja Kivinen Aarno Palotie Mari Kaunisto Kumar Veerapen Konrad J. Karczewski Alicia R. Martin Elizabeth G. Atkinson Kristin Tsuo Nikolas Baya Rahul Gupta Raymond K. Walters Duncan S. Palmer Gopal Sarma Nathan Cheng Wenhan Lu Claire Churchhouse Jacqueline I. Goldstein Daniel King Wei Zhou Cotton Seed Hilary Finucane F. Kyle Satterstrom Gita A. Pathak Akiko Iwasaki Karolina Chwialkowska Karolina Chwiałkowska Brooke N. Wolford Hajar Fauzan Ahmad Shea Andrews Kathrin Aprile von Hohenstaufen Puoti Palwende R. Boua Guillaume Butler-Laporte Celia M. T. Greenwood Bartha M. Knoppers Mark Lathrop Carmen L. Cadilla Francesca Colombo Nicole Dueker Chloe Kirk Atanu Kumar Dutta Yasser M. El-Sherbiny Jehan J. El-Jawhari Doaa Shahin Ahmed Elzeiny Tamer A. Mansour Madonna M. Eltoukhy Attia A. S. Mohamed Sahar Esmaeeli Annika Faucon Israel Fernández Cadenas Israel Fernandez-Cadenas Laia Llucià-Carol Natalia Cullell Elena Muiño Jara Cárcel-Márquez Margherita Francescatto Laurent Francioli Lindokuhle Nkambule Jatin Arora Soumya Raychaudhuri Caroline Cusick Lude Franke Macarena Fuentes Macarena Fuentes-Guajardo David Gómez Cabrero Emi N. Harry Philip Jansen József L. Szentpéteri Réka Várnai Elżbieta Kaja Athanasios Kousathanas Dorote Pasko Mark J. Caulfield Alex Stuckey Christopher A. Odhams Susan Walker Daniel Rhodes Richard H. Scott Loukas Moutsianas Afshan Siddiq Peter Goddard Sally Donovan Tala Zainy Fiona Maleady-Crowe Linda Todd Shahla Salehi Greg Elgar Georgia Chan Prabhu Arumugam Christine Patch Augusto Rendon Tom A. Fowler Jose E. Krieger Sanjay K. Patel Audrey Lemaçon Sophie Limou Pietro Lió Eirini Marouli Charles Hinds Minttu M. Marttila Carolina Medina-Gómez Isabelle Migeotte Soumyajit Mondal Andrés Moreno-Estrada Leire Moya Tomok Broad Institute of MIT and Harvard Cambridge MA USA Analytic and Translational Genetics Unit Massachusetts General Hospital Boston MA USA Program in Medical and Population Genetics Broad Institute of MIT and Harvard Cambridge MA USA Department of Biomedical Informatics Harvard Medical School Boston MA USA Program in Bioinformatics and Integrative Genomics Harvard Medical School Boston MA USA Institute for Molecular Medicine Finland (FIMM) University of Helsinki Helsinki Finland Institute for Molecular Medicine Finland University of Helsinki Helsinki Finland Institute for Molecular Medicine Finland (FIMM) HiLIFE University of Helsinki Helsinki Finland Public Health Faculty of Medicine University of Helsinki Helsinki Finland Analytic & Translational Genetics Unit Massachusetts General Hospital Boston MA USA Stanley Center for Psychiatric Research & Program in Medical and Population Genetics Cambridge UK Institute for Molecular Medicine Finland (FIMM) Univerisity of Helsinki Helsinki Finland University of California San Francisco San Francisco CA USA Department of Molecular and Human Genetics Baylor College of Medicine Houston TX USA Program in Biological and Biomedical Sciences Harvard Medical School Boston MA USA Department of Psychiatry School of Medicine Yale University New Haven CT USA Veteran Affairs Connecticut Healthcare System West Haven CT USA Yale University New Haven CT USA Centre for Bioinformatics and Data Analysis Medical University of Bialystok Bialystok Poland Department of Computational Medicine and Bioinformatics University of Michigan Ann Arbor MI USA Faculty of Industrial Sciences and Technology Universiti Malaysia Pahang Pahang Malaysia Icahn School of Medicine at Mount Sinai New York NY USA Genolier Innovation Network and Hub Swiss Medical Network Genolier Healthcare Campus Genolier Switzerland Immediate Independent Multidisciplinary Med & Biotech Research Association Milan Italy Clinical Research Unit of Nanor

来源：评论

学校读者我要写书评

暂无评论

Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies (vol 391, pg 1513, 2018)

引用

LANCET 2018年第10136期391卷 2212-2212页

作者： Wood, A. M. Kaptoge, S. Butterworth, A. S. [a]Department of Public Health and Primary Care University of Cambridge Cambridge UK [b]Medical University Innsbruck Innsbruck Austria [c]National Centre for Epidemiology and Population Health Australian National University Canberra Australia [d]MRC Biostatistics Unit Cambridge Institute of Public Health University of Cambridge Cambridge UK [e]NIHR BRC Nutritional Biomarker Laboratory University of Cambridge Cambridge UK [f]Norwegian Institute of Public Health Oslo Norway [g]National Institute for Public Health and the Environment Bilthoven Netherlands [h]Julius Centre for Health Sciences and Primary Care University Medical Center Utrecht Utrecht Netherlands [i]Chiba Prefectural Institute of Public Health Chiba Japan [j]Department of Community Medicine University of Tromsø Tromsø Norway [k]Nuffield Department of Population Health Medical Sciences Division University of Oxford Oxford UK [l]The George Institute for Global Health University of Sydney Sydney NSW Australia [m]Bloomberg School of Public Health Johns Hopkins University Baltimore MD USA [n]School of Medicine Johns Hopkins University Baltimore MD USA [o]THL-National Institute for Health and Welfare Helsinki Finland [p]Copenhagen University Hospital Copenhagen Denmark [q]Department of Clinical Medicine University of Copenhagen Copenhagen Denmark [r]School of Medicine University of Western Australia Perth WA Australia [s]Fiona Stanley Hospital Perth WA Australia [t]Harry Perkins Institute of Medical Research Perth WA Australia [u]London School of Hygiene & Tropical Medicine London UK [v]Department of Clinical Sciences Malmö Lund University Malmö Sweden [w]Graduate School of Public Health University of Pittsburgh Pittsburgh PA USA [x]CESP INSERM UMRS 1018 Villejuif Cedex France [y]Department of Epidemiology and Public Health University College London London UK [z]92 Deutsches Herzzentrum München Technische Universität München Munich Germany DZHK (German Centre for Cardiovascular R

Summary Background Low-risk limits recommended for alcohol consumption vary substantially across different national guidelines. To define thresholds associated with lowest risk for all-cause mortality and cardiovascular disease, we studied individual-participant data from 599 912 current drinkers without previous cardiovascular *** We did a combined analysis of individual-participant data from three large-scale data sources in 19 high-income countries (the Emerging Risk Factors Collaboration, EPIC-CVD, and the UK Biobank). We characterised dose-response associations and calculated hazard ratios (HRs) per 100 g per week of alcohol (12·5 units per week) across 83 prospective studies, adjusting at least for study or centre, age, sex, smoking, and diabetes. To be eligible for the analysis, participants had to have information recorded about their alcohol consumption amount and status (ie, non-drinker vs current drinker), plus age, sex, history of diabetes and smoking status, at least 1 year of follow-up after baseline, and no baseline history of cardiovascular disease. The main analyses focused on current drinkers, whose baseline alcohol consumption was categorised into eight predefined groups according to the amount in grams consumed per week. We assessed alcohol consumption in relation to all-cause mortality, total cardiovascular disease, and several cardiovascular disease subtypes. We corrected HRs for estimated long-term variability in alcohol consumption using 152 640 serial alcohol assessments obtained some years apart (median interval 5·6 years [5th-95th percentile 1·04-13·5]) from 71 011 participants from 37 *** In the 599 912 current drinkers included in the analysis, we recorded 40 310 deaths and 39 018 incident cardiovascular disease events during 5·4 million person-years of follow-up. For all-cause mortality, we recorded a positive and curvilinear association with the level of alcohol consumption, with the minimum mortality risk arou

关键词：

来源：评论

学校读者我要写书评

暂无评论

Alternative Healthy Eating Index 2010, Dietary inflammatory index and risk of mortality: Results from the Whitehall II cohort study and meta-analysis of previous DII and mortality studies (vol 118, pg 210, 2017)

引用

BRITISH JOURNAL OF NUTRITION 2017年第8期118卷 639-639页

作者： Shivappa, Nitin Hebert, James R. Kivimaki, Mika Akbaraly, Tasnime Cancer Prevention and Control Program University of South Carolina Columbia SC 29208 USA Department of Epidemiology and Biostatistics Arnold School of Public Health University of South Carolina Columbia SC 29208 USA Connecting Health Innovations LLC Columbia SC 29201 USA Department of Epidemiology and Public Health University College London London UK MMDN (Molecular Mechanisms of Neurodegenerative Diseases) INSERM (Institut National de la Santé et de la Recherche Médicale) U1198 EPHE (Ecole Pratique des Hautes Etudes) University Montpellier Montpellier F-34095France

We aimed to examine the association between the Alternative Healthy Eating Index updated in 2010 (AHEI-2010), the Dietary Inflammatory Index (DIITM) and risk of mortality in the Whitehall II study. We also conducted a meta-analysis on the DII-based results from previous studies to summarise the overall evidence. Data on dietary behaviour assessed by self-administered repeated FFQ and on mortality status were available for 7627 participants from the Whitehall II cohort. Cox proportional hazards regression models were performed to assess the association between cumulative average of AHEI-2010 and DII scores and mortality risk. During 22 years of follow-up, 1001 participants died (450 from cancer, 264 from CVD). Both AHEI-2010 (mean=48·7 (sd 10·0)) and DII (mean=0·37 (sd 1·41)) were associated with all-cause mortality. The fully adjusted hazard ratio (HR) per sd, were 0·82; 95 % CI 0·76, 0·88 for AHEI-2010 and 1·18; 95 % CI 1·08, 1·29 for DII. Significant associations were also observed with cardiovascular and cancer mortality risk. For DII, a meta-analysis (using fixed effects) from this and four previous studies showed a positive association of DII score with all-cause (HR=1·04; 95 % CI 1·03, 1·05, 28 891deaths), cardiovascular (HR=1·05; 95 % CI 1·03, 1·07, 10 424 deaths) and cancer mortality (HR=1·05; 95 % CI 1·03, 1·07, n 8269).The present study confirms the validity to assess overall diet through AHEI-2010 and DII in the Whitehall II cohort and highlights the importance of considering diet indices related to inflammation when evaluating all-cause, cardiovascular and cancer mortality risk.

关键词： Cohort Studies Mortality Meta-Analysis

来源：评论

学校读者我要写书评

暂无评论

Health Seeking Behaviors of Current and Former Smokers: 2015 National Health Interview Survey Results

引用

Annals of epidemiology 2017年第8期27卷 536-536页

作者： Cassie L. Odahowski Erica Sercy Jan M. Eberth Cancer Prevention and Control Program University of South Carolina Columbia SC Department of Epidemiology and Biostatistics University of South Carolina Columbia SC SC Rural Health Research Center University of South Carolina Columbia SC

来源：评论

学校读者我要写书评

暂无评论

Improvement in Dietary Inflammatory Index Score After Six-Month Dietary Intervention is Associated with Reduction in Interleukin-6 in Patients with Coronary Heart Disease: The AUSMED Heart Trial

引用

Heart, Lung and Circulation 2018年 27卷 S321-S322页

作者： H. Mayr C. Itsiopoulos A. Tierney M. Ruiz-Canela J. Hebert N. Shivappa C. Thomas Department of Rehabilitation Nutrition and Sport School of Allied Health La Trobe University Melbourne Australia Northern Health Epping Australia Department of Clinical Therapies University of Limerick Castleroy Ireland Department of Preventive Medicine and Public Health University of Navarra Navarra Spain CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn) Madrid Spain Cancer Prevention and Control Program and Department of Epidemiology and Biostatistics Arnold School of Public Health University of South Carolina USA Connecting Health Innovations LLC USA Department of Physiology Anatomy and Microbiology La Trobe University Melbourne Australia

来源：评论

学校读者我要写书评

暂无评论

Correction to: The association between the inflammatory potential of diet and risk of developing, and survival following, a diagnosis of ovarian cancer

引用

European journal of nutrition 2019年第4期58卷 1757页

作者： C M Nagle T Ibiebele N Shivappa J R Hébert A DeFazio P M Webb Gynaecological Cancers Group QIMR Berghofer Medical Research Institute Locked Bag 2000 Royal Brisbane Hospital Herston QLD 4029 Australia. christina.nagle@qimrberghofer.edu.au. Faculty of Medicine School of Public Health The University of Queensland Brisbane Australia. christina.nagle@qimrberghofer.edu.au. Gynaecological Cancers Group QIMR Berghofer Medical Research Institute Locked Bag 2000 Royal Brisbane Hospital Herston QLD 4029 Australia. Cancer Prevention and Control Program University of South Carolina 915 Greene Street Suite 241-2 Columbia SC 29208 USA. Department of Epidemiology and Biostatistics Arnold School of Public Health University of South Carolina 915 Greene Street Suite 400 Columbia SC 29208 USA. Connecting Health Innovations LLC (CHI) 1417 Gregg Street Columbia SC 29201 USA. Centre for Cancer Research The Westmead Institute for Medical Research The University of Sydney Sydney Australia. Department of Gynaecological Oncology Westmead Hospital Sydney Australia. Faculty of Medicine School of Public Health The University of Queensland Brisbane Australia.

In the original publication of this article on page 6, paragraph "Discussion", line 4, 'In a U.S. population-based case-control study (n = 493 cases) Peres et al., reported a non-significant association between DII score and risk of developing ovarian cancer of similar magnitude (OR DII score 1.35, 95% CI 0.93-1.97) [20]'. It should read as 'In a U.S. population-based case-control study (n = 493 cases) Peres et al., reported a significant association between DII score and risk of developing ovarian cancer (OR DII score 1.72, 95% CI 1.18-2.51) [20]'.

关键词：

来源：评论

学校读者我要写书评

暂无评论

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

请选择保存的检索档案：

请选择收藏分类：

通借通还

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：